Nami Therapeutics Corp (’Nami’) is a startup company based in Storrs, CT and currently in the Technology Incubation Program at the University of Connecticut. Nami is developing specifically designed nanoparticles for the targeted delivery of therapeutic agents, including radio-therapeutics, to tumors. Nami (which mean ‘nano’ in Mandarin) is using technologies licensed from the University of Connecticut and the University of North Carolina. The Nami team is comprised of Xiuling Lu and Michael Jay, academics with over 50 years of collective experience in the drug delivery field, Ruobing Xia, who has 20+ years of experience in big pharma managing multi-million dollar product launches, and David Worthen, an experienced scientist and entrepreneur with product development, regulatory affairs, and management experience in both industry and academia.
Nami aims to advance it nanotechnology-based products to the clinical trial stage by demonstrating the efficacy of its products in preclinical models, and by completing IND enabling activities such as manufacturing process development (CMC) and safety/toxicity assessments.
Company Details
- Employees
- 5
- Founded
- 2018
- Address
- 1392 Storrs Road,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- namitherapeutics.com
- Keywords
- Modulation Therapeutics.
- HQ
- Storrs, CT
Nami Therapeutics Corporation Questions
Nami Therapeutics Corporation's website is namitherapeutics.com
Nami Therapeutics Corporation's LinkedIn profile is https://www.linkedin.com/company/nami-therapeutics
Nami Therapeutics Corporation has
5 employees.
View email and phone details for 5
employees at Nami Therapeutics Corporation.
Nami Therapeutics Corporation's industry is
Pharmaceutical Manufacturing
Nami Therapeutics Corporation's top competitors are
Modulation Therapeutics,
Noble Registry,
Lisym-Cancer,
Arronax,
Modulation Therapeutics,
The Scott Family Office Intl. ("tsfo Intl."),
Ashvattha Therapeutics, Llc,
Full-Life Technologies,
Edinburgh Molecular Imaging Ltd,
Center For Pharmaceutical Processing Research (Cppr).
Nami Therapeutics Corporation's categories are Pharmaceutical Manufacturing
Nami Therapeutics Corporation's founding year is 2018
